GovGazette
Menu

Historical award

Biomerieux Inc

This record is historical buying context, not open work.

How current is this award history?

Fiscal year 2025: data through (16 days old).

Fiscal year 2026: data through (16 days old).

Official release availability details

Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.

Availability checked: .

Current award value
$11,973.13
Potential award value
$11,973.13
Total obligated to date
$11,973.13

Recorded work

BIOMERIEUX'S NUCLISENS REAGENTS TO BE USED ON THEIR SAMPLE EXTRACTION PLATFORMS THAT HAVE BEEN VALIDATED FOR HIV DRUG RESISTANCE: NUCLISENS EASYMAG, EMAG AND THE MINIMAG WHICH ARE USED BY THE MOLECULAR DIAGNOSTIC AND SURVEILLANCE TEAM'S SURVEILLANCE

Award activity

Obligations in covered fiscal years
−$736.45
Transactions in covered fiscal years
1

Award value and obligated funds describe different amounts. Review the official record for the full transaction history.

Record identifierCONT_AWD_75D30124P00045_7523_-NONE-_-NONE-